These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3486176)

  • 1. [Clinical and immunologic studies of the use of thymus polypeptide factor (thymostimulin) in chronic mucocutaneous candidiasis].
    Lutz G; Niedecken HW; Bauer R; Kreysel HW
    Hautarzt; 1986 Mar; 37(3):142-5. PubMed ID: 3486176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic mucocutaneous candidiasis with 5-fluorocytosine.
    Lin CY
    Ann Allergy; 1982 Nov; 49(5):298-300. PubMed ID: 6756218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic candidiasis: treatment with bovine thymic extract. Case report].
    Trevisan G; Kokelj F; Perticarari S; Dobrinz MG; Meraviglia L
    G Ital Dermatol Venereol; 1982; 117(3):161-4. PubMed ID: 7187396
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic mucocutaneous candida mycosis (CMCC) caused by a T-cell defect].
    Rytter M; Schönborn C; Lohrisch I; Haustein UF
    Z Gesamte Inn Med; 1986 Apr; 41(7):214-6. PubMed ID: 3521108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
    Mobacken H; Lindholm L; Moberg S
    Acta Derm Venereol; 1987; 67(3):257-60. PubMed ID: 2442942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood lymphocyte changes after benign gastrointestinal surgery. Role of thymostimulin in reversing the postoperative immunodepression seen in humans.
    Garcia-Valdecasas JC; Martinez A; Lopoez-Boado MA; de Lacy AM; Cugat E; Grande L; Fuster J; Visa J; Pera C
    Hepatogastroenterology; 1988 Oct; 35(5):219-22. PubMed ID: 2976389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole in a case of chronic mucocutaneous candidiasis.
    Zachariae H; Laurberg G; Thestrup-Pedersen K
    Acta Derm Venereol; 1982; 62(1):87-9. PubMed ID: 6175153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of combined immunodeficiency with thymic extract (Thymostimulin).
    Lin CY; Hsu HC; Chen CL; Shen EY
    Ann Allergy; 1987 May; 58(5):379-84. PubMed ID: 3578932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired generation of helper T cells in a patient with chronic mucocutaneous candidiasis and malignant thymoma.
    Ruiz-Argüelles A; Jett JR; Ritts RE
    J Clin Lab Immunol; 1983 Mar; 10(3):165-9. PubMed ID: 6221110
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketoconazole treatment of chronic mucocutaneous candidiasis.
    Montagnani A; Negosanti M; Patrizi A
    Drugs Exp Clin Res; 1986; 12(5):409-12. PubMed ID: 3522160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy.
    Lazzarin A; Galli M; Moriondo P; Parravicini C; Poli G; Moroni M
    J Clin Lab Immunol; 1986 Jun; 20(2):57-61. PubMed ID: 2942692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic mucocutaneous candidiasis. Cutaneous expression of immunologic anomalies. Report of a case].
    Pérez Suárez de Durandeau L; Salinas Carmona MC; Silva Siwady JG; Hinojosa Ayala JR
    Med Cutan Ibero Lat Am; 1986; 14(5):357-63. PubMed ID: 3543557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic mucocutaneous candidiasis with deficient CD2 (E receptor) but normal CD3 mononuclear cells.
    Noh LM; Hussein SH; Sukumaran KD; Rose I; Abdullah N
    J Clin Lab Immunol; 1991 Jun; 35(2):89-93. PubMed ID: 1688166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pneumocystis carinii pneumonia in a 15-year-old with chronic mucocutaneous candidiasis.
    Eppinger TM; Aronson JE; Fonacier LS; Cunningham-Rundles C
    Scand J Infect Dis; 1999; 31(2):203-6. PubMed ID: 10447335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T-lymphocyte subpopulations in autoimmune and subacute thyroiditis treated with T-activin].
    Sakaeva NA; Balabolkin MI; Tabagari DZ
    Sov Med; 1989; (10):39-41. PubMed ID: 2617340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor T cells role in the unresponsiveness to Candida albicans in chronic mucocutaneous candidiasis.
    Barnaba V; Zaccari C; Levrero M; Balsano F
    Boll Ist Sieroter Milan; 1985; 64(2):126-30. PubMed ID: 3161525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoma and late onset mucocutaneous candidiasis associated with a plasma inhibitor of cell-mediated immune function.
    Gatenby P; Basten A; Adams E
    J Clin Lab Immunol; 1980 May; 3(3):209-16. PubMed ID: 7420408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymostimulin in the antiinfectious treatment in patients with burns.
    Schiavon M; Chiarelli A; Löhr G; Mazzoleni F
    Arzneimittelforschung; 1987 May; 37(5):557-60. PubMed ID: 3497638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole.
    Williamson MM; Gordon RD
    Med J Aust; 1983 Mar; 1(6):276-8. PubMed ID: 6298584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host factors in defense against fungal infections.
    Kirkpatrick CH
    Am J Med; 1984 Oct; 77(4D):1-12. PubMed ID: 6388323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.